MedInsider Clinic MedInsider Store
---

Medicine Details

Erlotero 150mg Tablet

Manufacturer: Hetero Drugs Ltd

Salt Composition: Erlotinib (150mg)

Medicine Type: allopathy

Introduction: In Non-small cell lung cancer Non-small cell lung cancer is one of the major kinds of lung cancer and it affects both smokers as well as non-smokers. Erlotero 150mg Tablet helps treat non-small cell lung cancer and may be given alone or in combination with other medicines. It is a potent and very toxic medicine and you should discuss the risks and benefits with your doctor. You should avoid drinking alcohol while having this treatment and drink plenty of water to stay hydrated. In Pancreatic cancer Pancreas are very essential for digestion of whatever you eat and also for metabolism of blood sugar levels as they produce the body’s natural insulin. This medicine will help to control pancreatic cancer, and will relieve the symptoms such as, lack of appetite or unexplained weight loss. Erlotero 150mg Tablet helps to stop the action of those chemicals that aid in pancreatic cancer growth and spread. It will help you live a longer and healthier life.

Benefits: Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Erlotero 150mg Tablet is to be taken empty stomach.

Description: Erlotero 150mg Tablet is used in the treatment of non-small cell lung cancer and pancreatic cancer. Erlotero 150mg Tablet should be taken on an empty stomach or should be taken one hour before or 2 hour after meal. You should continue to take it as long as your doctor advises it. The duration of treatment varies according to your needs and response to treatment. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to. The most common side effects of this medicine include nausea, vomiting, fatigue, rash, and weight loss. It may cause severe diarrhea, drink plenty of fluids or consult with your doctor if it bothers you. It makes you sensitive towards sunlight, hence wear protective clothing or use sunscreen while going out. In case you develop ulceration in mouth, changes in your vision, or breathing difficulties than it is better to inform the doctor. Your doctor may advise for regular monitoring of liver function while you are taking this medicine. Many other medicines can affect, or be affected by, this medicine so let your healthcare team know all medications you are using. This medicine is not recommended during pregnancy or while breastfeeding. The use of effective contraception by both males and females during treatment is important to avoid pregnancy. It is advised to quit smoking while taking this medicine as it can affect the working of the medicine. If you have to take an antacid or any other medicine, take it at a gap of at least 2 hours after taking the cancer medicine.

How to Use: Erlotero 150mg Tablet is an anti-cancer medication. Epidermal growth factor receptors (EGFR) are expressed on the lung cancer cell surfaces that modulate their growth. This medicine works by binding the chemical messenger, EGFR, hence, inhibits the cancer signaling pathways mediated by EGFR. This is how it restricts further growth of the cancer cells.

Safety Advice: If you miss a dose of Erlotero 150mg Tablet, skip it and continue with your normal schedule. Do not double the dose.

If Missed: strip of 30 tablets

Packaging: Strip

Packaging Type:

Primary Use: Non-small cell lung cancer | Pancreatic cancer

Side Effects: Bone pain | Breathlessness | Constipation | Cough | Diarrhea | Fatigue | Fever | Infection | Muscle pain | Nausea | Rash | Stomatitis (Inflammation of the mouth) | Vomiting | Weight loss

Alcohol Interaction: CONSULT YOUR DOCTOR

Pregnancy Interaction:

Lactation Interaction: CONSULT YOUR DOCTOR

Driving Interaction:

Kidney Interaction: SAFE IF PRESCRIBED

Liver Interaction: CAUTION